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Components of the Japanese diet, which might contribute to the relatively low breast cancer incidence rates in Japan, have not been
clarified in detail. Since soybean products are widely consumed in Japan, a case–control study taking account of the menopausal
status was conducted using data from the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC). In
total, 167 breast cancer cases were included and 854 women confirmed as free of cancer were recruited as the control group. Odds
ratios (OR) and 95% confidence intervals (95% CI) were determined by multiple logistic regression analysis. There were reductions in
risk of breast cancer associated with high intake of soybean products among premenopausal women. Compared with women in the
lowest tertile, the adjusted ORs for top tertile intake of tofu (soybean curd) was 0.49 (95% CI, 0.25–0.95). A significant decrease in
premenopausal breast cancer risk was also observed for increasing consumption of isoflavones (OR¼0.44; 95% CI, 0.22–0.89 for
highest vs lowest tertile; P for trend¼0.02). The present study found a statistically inverse association between tofu or isoflavone
intake and risk of breast cancer in Japanese premenopausal women, while no statistically significant association was evident with the
risk among postmenopausal women.
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Despite a marked increase in recent years, the incidence rates for
female breast cancer in most Asian countries are much lower
than those in the Western world (Parkin et al, 1997). Much of
the international variation is due to differences in established
reproductive risk factors, such as age at menarche, parity and age
at first birth, but dietary habits might also contribute. Dietary
studies of breast cancer have typically focused on the hypothesis
that there is a positive link with intake of fat. While ecological
studies have suggested associations in terms of incidence and
mortality, leading prospective studies of breast cancer, including
the Nurse’s Health Study (Stampfer et al, 1987) and studies of large
cohorts from New York (Toniolo et al, 1994) and Norway (Vatten
et al, 1990) have shown no relation (Willett, 1997). Recently, there
has been more interest in other dietary factors, such as soybean
products, which may protect against breast cancer and provide an
explanation for some of the international differences in incidence
rates (Adlercreutz, 1990; Messina and Barnes, 1991).
Soybeans provide a unique concentrated source of isoflavones
and soybeans or isoflavones have been shown to exert anti-
carcinogenic effects on hormone-related cancers in a large number
of experimental studies. Despite the growing interest in the
protective effects, there are relatively few epidemiological data
available since soybean products are consumed mainly by Asian
populations. In Japan, intake is in various forms, including tofu
(soybean curd), okara (tofu lees), moyashi (soybean sprouts),
tonyu (soymilk), yuba (soy milk skin), kinako (soy flour), miso
(fermented soybean paste), atsuage (deep fried tofu), aburage
(thinly sliced deep fried tofu), natto (fermented soybeans),
koyadofu (freeze dried tofu) and shoyu (soy sauce), so that the
diet is likely to be much richer in isoflavones than in the Western
world, where the diet usually does not include soybeans. We here
evaluated the association between risk of breast cancer and
consumption of soybean products and isoflavones using data from
the hospital-based epidemiologic research program at Aichi
Cancer Center (HERPACC).
MATERIALS AND METHODS
Data collection
Details of the study design and subject characteristics have been
described elsewhere (Yoo et al, 1992; Hirose et al, 1995, 1999,
2001). In brief, we have conducted the HERPACC study since 1988,
whereby questionnaire survey is completed by first-visit out-
patients to the Aichi Cancer Center Hospital (ACCH) (Tajima et al,
2000). All questionnaires are then collected after checking for
incomplete responses by a trained interviewer and the data
are loaded into the computer system of the Aichi Cancer Center
Research Institute. The data collected are linked with the
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shospital-based cancer registry files. This study was approved by
the Institutional Review Board, and all participants provided
written, informed consent.
The questionnaire included questions on occupation, medical
history, height, weight, weight at around 20 years of age, family
history (parents and siblings), smoking and drinking habits,
sleeping habits, physical exercise and reproductive history. The
details were taken prior to assessment of symptoms and all
information was collected before clinical diagnoses were made.
Cases and controls
The present analysis was restricted to women aged 30 and over
who visited hospitals between January 2001 and March 2002. As
eligible cases, 79 premenopausal and 88 postmenopausal women
diagnosed as having breast cancer by histological examination
within 6 months of the first-visit were recruited. A methodological
study applying the same HERPACC data set earlier showed that the
OR based on a large number of controls gives more power and
steadier estimates than the use of matched controls (Hamajima
et al, 1994); therefore, we used all noncancer individuals as
candidates for controls in this study. As the controls, 854 female
first-visit outpatients who had never been diagnosed as having
cancer were recruited. Table 1 summarises details for the 167 cases
and 854 controls by age group and selected characteristics.
Exposure data
The interview included a validated, semiquantitative food-
frequency questionnaire (FFQ) (Tokudome et al, 1998, 2001;
Imaeda et al, 2002). Dietary intake was ascertained using a detailed
quantitative FFQ, including 119 food items/recipes, and the
following food groups were included: (a) meat and meat products
(poultry, ground meat, pork meat, beef, ham, sausage, bacon,
liver); (b) fish and fish products (salmon, eel, pale blue fleshed
fish, red fleshed fish, white fleshed fish, squid, octopus, shrimp,
crab, dried fish larvae, small bony fish, tuna canned in oil, cod roe,
oyster, shellfish, dried squid, fried fish paste, fish paste sausage);
(c) green-yellow vegetables (green leafy vegetables, pumpkin,
carrot, broccoli, green pepper, green soybean, green beans,
tomato); (d) other vegetables (cabbage, Japanese radish, burdock,
bamboo shoots, cucumber, eggplant, lettuce, bean sprout, onion,
Chinese cabbage, Japanese radish); (e) fruits (oranges, mandarin
oranges, persimmon, banana, apple, strawberries, kiwi, peach,
grapes, watermelon, melon, Japanese pears); (f) dairy products
(low fat milk, medium fat milk, high fat milk, calcium enriched
milk and yoghurt, skim milk, lactic acid bacteria beverage,
yoghurt, cheese, ice cream).
Furthermore, the following soybean products were included: (a)
tofu (soybean curd); (b) miso (fermented soybean paste); (c)
atsuage (deep fried tofu); (d) aburage (thinly sliced deep fried
tofu); (e) natto (fermented soybeans); (f) koyadofu (freeze dried
tofu). We evaluated validity of intakes based on the questionnaire
against those according to 28-day (four-season consecutive 7-day)
weighted diet records among 79 Japanese female dietitians. In the
validation study, the Spearman’s correlation coefficients between
the estimate intake of soybean products and isoflavone from the
questionnaire and that from dietary records were 0.51, 0.53,
respectively. For reproducibility of estimation from the ques-
tionnaire, the Spearman’s correlation coefficients for the con-
sumption of soybean products and isoflavone intake between two
questionnaires administered 1 year apart were 0.57 and 0.47,
respectively.
All subjects in the present study were asked for average
frequency and portion size of consumption, during the period of
1 year before onset of the present disease or before the interview.
There were eight categories of possible responses, ranging from
‘rarely or never’ to ‘three or more times per day’. For each food, a
commonly used unit or portion size was specified and the
interviewers asked the subjects using sampling models of full-
scale photographs. We ascertained average amount of daily
consumption of each food and nutrients by multiplying the food
intake (in grams) or serving size and the nutrient content per 100
grams of food as listed in the Standard Tables of Food
Composition, Version 5 and the Follow-up of Standard Tables of
Food Composition (Science and Technology Agency, Japan, 1994,
2001). Isoflavone intakes were separately calculated from USDA-
Iowa State University Database on the Isoflavone Content of
Table 1 Basic characteristics of cases and controls
Cases
(n¼167)
Controls
(n¼854)
Age (years)
30–39 19 (11.4%) 99 (11.6%)
40–49 46 (27.5%) 279 (32.7%)
50–59 54 (32.3%) 280 (32.8%)
X60 48 (28.7%) 196 (23.0%)
Mean age (s.d.) 52.7 (10.2) 51.4 (10.5)
Motives for consultation
Self-recommendation 47 (28.1%) 286 (33.5%)
Family recommendation 43 (25.8%) 194 (22.7%)
Referral from other clinics 44 (26.4%) 139 (16.3%)
Secondary screening after primary screening 33 (19.8%) 224 (26.2%)
Others 0 (0.0%) 6 (0.7%)
Unknown 0 (0.0%) 5 (0.6%)
Smoking status
Never 146 (87.4%) 710 (83.2%)
Ever 9 (5.4%) 51 (6.0%)
Current 12 (7.2%) 91 (10.7%)
Unknown 0 (0.0%) 1 (0.1%)
Drinking status
Never 111 (66.5%) 546 (63.9%)
Ever 0 (0.0%) 13 (1.5%)
Current 56 (33.5%) 295 (34.5%)
Exercise
No 54 (32.3%) 291 (34.1%)
p60min/week 33 (19.8%) 192 (22.5%)
p120min/week 27 (16.2%) 126 (14.8%)
4120min/week 47 (28.1%) 225 (26.4%)
Unknown 6 (3.6%) 20 (2.3%)
Mean BMI (s.d.) 22.9 (3.1) 22.0 (3.0)
Mean of age at first birth (s.d.) 25.8 (3.6) 25.7 (3.5)
Mean of age at menarche (s.d.) 13.5 (1.5) 13.4 (1.6)
Parity
Parous 155 (93.4%) 763 (89.7%)
Nulliparous 11 (6.6%) 88 (10.3%)
Menopausal status
Premenopausal 79 (47.3%) 414 (48.5%)
Postmenopausal 88 (52.7%) 440 (51.5%)
Age at menopause among postmenopausal
women
p47 24 (27.3%) 105 (23.9%)
48–52 42 (47.7%) 225 (51.1%)
X53 22 (25.0%) 83 (18.9%)
Unknown 0 (0.0%) 27 (6.1%)
Family history
a
No 153 (91.6%) 791 (92.6%)
Yes 14 (8.4%) 63 (7.4%)
s.d.¼standard deviation.
aFamily history in mother or sisters.
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sFoods, Release 1.3-2002 (http://www.nal.usda.gov/fnic/foodcopm/
Data/isoflav/isoflav.html). Isoflavone intake was calculated using
consumption of six items of soybean products, green soybean,
peanuts, Japanese green tea, and vegetables other than green-
yellow vegetables such as cucumber, eggplant, lettuce, bean
sprouts, onion, Chinese cabbage.
Statistical analysis
Dietary intake data were analysed by individual food items, food
groups and nutrients for all subjects combined and separately for
premenopausal and postmenopausal women. The differences of
means were examined by t-test and all P-values presented are
two-sided.
Logistic regression analysis was used to obtain odds ratios (ORs)
and 95% confidence intervals (95% CI) as estimates of relative risk.
The P-value for trend corresponded to the estimate of the slope
derived from the logistic model in the case that the integers, 1 to n,
were assigned to the ordered n levels of each factors. The
LOGISTIC procedure provided by SAS (SAS Institute, Cary, NC,
USA) was utilised to perform the calculations. To compare
differences and similarities of effects of Japanese diet on risk for
breast cancer, subjects were stratified with reference to menopau-
sal status. The ORs of breast cancer are calculated for the selected
food groups and isoflavone intake in tertiles, with the lowest
tertile as the referents. Multivariate models was adjusted for age,
energy (as a continuous variable), motives for consultation
(self-recommendation, family recommendation, referral from
other clinics, secondary screening after primary screening, others),
smoking status (never, ever, current), drinking status (never,
ever, current), exercise (none, p60min/week, p120min/week,
4120min/week), family history (yes or no), age at menarche
(p12, 13, X14), parity (0,1,2, 3þ), age at first full-term pregnancy
(p23, 24–27, X28), and current body mass index (BMI) (p20,
20–25, X25). Further, inclusion in the model of age at menopause
(p47, 48–52, X53) was performed with the calculations for
postmenopausal women. Energy was adjusted for the multivariate
nutrient density method.
A positive family history may involve different types and
numbers of relatives. Distant relatives share less genetic influence
and fewer confounding environmental and/or behavioral factors
than do close ones. Furthermore, information on the medical
history of distant relatives is limited and less precise than that of
close or first-degree relatives. In this study, the presence of either a
mother or sister with breast cancer was considered as a positive
family history. BMI was calculated as weight/height
2 (kgm
 2),
according to Quetelet’s formula and current BMI values were
stratified into three categories. Since a BMIX25 is defined as obese
by the Japanese Society for the Study of Obesity, the cutoff for the
highest BMI group was BMIX25.
RESULTS
Table 2 summarises data for daily intake of some nutrients and
consumption of selected food groups among cases and controls.
There were no significant differences between cases and controls in
intake of energy and fat. The means of meat and meat products
intakes per day was 60.7g (standard deviation (s.d.), 34.7g) and
67.0g (s.d., 39.4g), respectively, for cases and controls (Po0.04).
Among premenopausal women, the means of soybean products
were 51.7g (s.d., 31.2g) in case group and 63.5g (s.d., 38.8g) in
control group (Po0.01, data not shown). Breast cancer cases
reported lower total isoflavones intake per day than controls, with
averages of 20.8mg (s.d., 10.8mg) and 25.8mg (s.d., 14.3mg),
respectively (Po0.0001, data not shown) among premenopausal
women. We observed no other significant differences among
premenopausal women and there were no significant differences
Table 2 Distribution of selected dietary variables (intake/day) among breast cancer cases and controls
Cases Controls
Percentile Percentile
Nutritional factors and food items Mean 25 50 75 Mean 25 50 75
Nutritional factors
Energy (kcal) 1831 1568 1791 2038 1859 1593 1835 2093
Total protein (g) 72.1 59.0 70.1 83.0 73.7 60.8 72.1 83.7
Total fat (g) 57.5 43.5 55.0 70.6 59.1 45.5 57.9 70.4
% of energy (%) 27.9 25.0 28.7 31.4 28.4 24.3 28.5 32.3
Carbohydrate (g) 252.9 220.8 243.6 279.7 254.7 217.5 249.8 289.7
Total dietary fibre (g) 14.4 11.4 13.6 16.7 14.8 11.5 14.2 17.2
Vitamin C (mg) 161.5 115.6 152.1 194.4 164.9 108.4 146.3 199.3
Vitamin E (mg) 10.1 7.9 9.7 12.1 10.3 8.1 10.0 12.1
Isoflavones (mg) 24.8 15.3 21.3 30.3 27.1 17.0 24.2 32.5
Food items
Meat and meat products (g) 60.7 36.4 55.7 77.9 67.0 38.6 61.6 90.0
Fish and fish products (g) 56.5 38.9 52.9 68.6 56.8 36.0 52.9 71.4
Green-yellow vegetables (g) 136.5 78.2 118.9 173.2 144.6 78.2 118.0 180.4
Other vegetables (g) 130.7 82.5 115.7 154.3 135.8 88.2 125.4 172.1
Fruit (g) 164.5 83.4 142.1 217.0 167.1 84.1 143.3 219.7
Dairy products (g) 200.2 87.1 189.3 274.3 199.0 96.8 188.9 265.0
Soybean products (g) 63.4 35.5 53.5 82.4 67.7 39.5 60.5 84.3
Tofu (soybean curd) (g) 39.0 20.0 29.0 50.0 41.7 23.0 35.0 52.0
Miso (fermented soybean paste) (g) 6.3 2.0 5.0 10.0 7.1 5.0 8.0 10.0
Atsuage (deep fried tofu) (g) 7.4 2.5 5.0 10.0 7.3 2.5 5.0 10.0
Aburage (thinly sliced deep fried tofu) (g) 1.7 0.6 1.2 3.0 1.7 0.6 1.2 2.4
Natto (fermented soybeans) (g) 9.2 4.0 7.2 10.0 10.3 4.0 8.0 16.0
Koyadofu (freeze dried tofu) (g) 1.9 0.0 0.0 4.0 2.0 0.0 0.0 4.0
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nutrients among postmenopausal women.
Among premenopausal women, breast cancer risk was inversely
associated with consumption of soybean products (Table 3). The
ORs was 0.53 (95% CI, 0.27–1.04) for the top tertile of soybean
product intake compared with the lowest tertile of intake (trend
test, P¼0.06). Among postmenopausal women, on the other hand,
consumptions of soybean products, meat and meat products, fish
and fish products, vegetables, fruits, dairy products were not
associated with the risk of breast cancer.
The ORs for breast cancer according to type of soybean product
are presented in Table 4. A statistically significant inverse relation
was observed between tofu consumption and breast cancer in
premenopausal women. ORs were 0.44 (95% CI, 0.22–0.90), 0.49
(95% CI, 0.25–0.95) for the second to the top tertiles of intake
compared with the lowest tertile of intake of tofu (trend test,
P¼0.03). Compared with those in the lowest tertile of atsuage
(deep fried tofu) consumption, the adjusted OR for breast cancer
in top tertile was 0.70 (95% CI, 0.35–1.38) among premenopausal
women. On the other hand, a significantly increased risk of breast
cancer with consumption of atsuage was observed in postmeno-
pausal women. The adjusted OR for top tertile of atsuage
consumption was 2.28 (95% CI, 1.15–4.51, trend test P¼0.02).
Also, consumption of aburage (thinly sliced deep fried tofu)
showed a similar positive association with the risk of breast cancer.
There were no associations with intake of tofu, miso and natto
intake among postmenopausal women. With intake of koyadofu
(freeze dried tofu) divided into tertiles, there was no apparent
modification of the breast cancer risk among either pre- or
postmenopausal women.
We next determined the association between total intake of
isoflavone and risk of breast cancer and found a statistically
significant inverse association among premenopausal women.
Compared with women in the lowest tertile of isoflavone
consumption, the top tertile had an adjusted OR of 0.44 (95%
CI, 0.22–0.89; trend test P¼0.02). Among postmenopausal women
the similar trend was also observed; however, there was no
statistically significant association between consumption of
isoflavone and breast cancer risk (Table 5).
DISCUSSION
The present study found a statistically inverse association between
risk of breast cancer and soybean products (tofu) or isoflavones
intake in Japanese premenopausal women while there was no
statistically significant link among their postmenopausal counter-
parts.
Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer according to food group intake by menopausal status
Premenopausal women Postmenopausal women
OR for tertiles of food group intake (g/1000kcal) OR for tertiles of food group intake (g/1000kcal)
123 P-value test 1 2 3 P-value test
Meat and meat products
Tertile median 24.3 38.4 54.4 13.7 29.4 45.7
Cases/controls 29/138 31/137 19/139 31/146 39/147 18/147
OR
a 1.00 1.02 0.54 0.11 1.00 1.11 0.64 0.24
(95% CI) (0.54–1.92) (0.26–1.12) (0.62–2.02) (0.32–1.28)
Fish and fish products
Tertile median 14.8 25.6 38.5 18.2 30.6 45.4
Cases/controls 21/138 29/138 29/138 26/145 37/147 25/148
OR
a 1.00 1.53 1.36 0.46 1.00 1.42 0.77 0.42
(95% CI) (0.74–3.18) (0.65–2.88) (0.75–2.66) (0.39–1.52)
Vegetables
b
Tertile median 80.4 125.3 189.6 98.6 145.2 220.5
cases/controls 22/138 39/138 18/138 31/146 30/146 27/148
OR
a 1.00 1.45 0.70 0.38 1.00 1.01 0.85 0.63
(95% CI) (0.76–2.80) (0.32–1.50) (0.54–1.89) (0.44–1.63)
Fruit
Tertile median 27.5 62.3 115.4 46.3 93.7 158.5
Cases/controls 28/139 29/136 22/139 24/146 32/147 32/147
OR
a 1.00 1.08 0.65 0.24 1.00 1.21 1.38 0.34
(95% CI) (0.55–2.10) (0.32–1.33) (0.62–2.35) (0.71–2.69)
Dairy products
Tertile median 34.0 98.5 158.5 32.3 103.6 165.5
Cases/controls 30/139 22/136 27/139 22/146 31/147 35/147
OR
a 1.00 0.91 0.73 0.37 1.00 1.54 1.64 0.15
(95% CI) (0.46–1.79) (0.37–1.45) (0.80–2.96) (0.84–3.20)
Soybean products
Tertile median 17.2 29.7 47.9 20.1 35.3 56.5
Cases/controls 36/139 23/137 20/138 31/146 28/147 29/147
OR
a 1.00 0.60 0.53 0.06 1.00 0.87 0.70 0.28
(95% CI) (0.30–1.18) (0.27–1.04) (0.47–1.61) (0.37–1.33)
aAdjusted for age, motives for consultation, smoking, drinking, exercise, energy, family history, age at menarche, parity, age at first full-term pregnancy, BMI and age at menopause
for postmenopausal women.
bIncluded both green-yellow vegetabeles and other vegetables.
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sSoybean foods are rich in precursors of the isoflavone daidzein
and genistein, which are heterocyclic phenols similar in structure
to oestrogens, and it has been hypothesised that a high dietary
intake of soybean products might reduce breast cancer risk by
interfering with the action of endogenous oestradiol (Messina,
1999). The results are in line with the inverse association between
intake of soybean products and breast cancer risk suggested from
ecological/cross-sectional studies (Adlercreutz, 1995; Adlercreutz
and Mazur, 1997), and also from analytical investigations. Thus,
case–control studies have found that soybean food intake was
associated with a decreased risk of breast cancer among
premenopausal Singapore women (Lee et al, 1991), and both
pre- and postmenopausal Asian-American women (Wu et al,
1996), although a Chinese case–control study failed to detect any
protective effects of soybean food (Yuan et al, 1995). Cohort
studies among Japanese (Hirayama, 1990; Yamamoto et al, 2003),
Japanese-American (Nomura et al, 1978) and Caucasian-American
women (Greenstein et al, 1996) have also provided some evidence
that soybean products may reduce the risk of breast cancer. A
prospective study conducted in Japan, however, found no link
between soya consumption and breast cancer risk, but in this case
the subjects were city residents in Hiroshima or Nagasaki exposed
to high doses of ionising radiation and therefore the cohort was
unusual (Key et al, 1999). A recent cohort study based on public
health center in Japan (Yamamoto et al, 2003) found frequent miso
soup and isoflavone consumption to be associated with a reduced
risk of breast cancer and the protective effect was stronger in
postmenopausal women. However, the FFQ applied included only
two items for soybean-ingredient foods (i.e. miso soup and
soyfoods), making it impossible to investigate differences in
effects among types of soybean-ingredient foods.
Isoflavone intake by Japanese is much higher than that by
Western populations (Jones et al, 1989; Kimira et al, 1998). Tofu,
miso and natto were main foods containing rich isoflavones.
Attributable rate of genistein were tofu (49.6%), miso (20.9%),
natto (14.7%) among Japanese. In the present study, tofu was
protective in premenopausal women, while atsuage and aburage,
deep fried tofu containing much oil, was associated with elevated
risk among postmenopausal women. This may be due to fat intake,
which can exert an influence on the development of breast cancer
among postmenopausal women. Some studies have suggested that
high intake of soybean products in premenopausal women may
Table 4 Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer according to soybean product intake by menopausal status
Premenopausal women Postmenopausal women
OR for tertiles of soybean product intake
(g/1000kcal)
OR for tertiles of soybean product intake
(g/1000kcal)
12 3 P-value test 1 2 3 P-value test
Tofu (soybean curd)
Tertile median 8.9 17.1 31.3 10.8 19.6 35.9
Cases/controls 38/137 20/139 21/137 26/145 36/148 26/147
OR
a 1.00 0.44 0.49 0.03 1.00 1.34 0.71 0.34
(95% CI) (0.22–0.90) (0.25–0.95) (0.73–2.44) (0.36–1.39)
Miso (fermented
soybean paste)
Tertile median 1.4 3.4 5.5 1.5 3.9 5.8
Cases/controls 30/137 30/137 19/136 37/145 23/147 28/147
OR
a 1.00 1.14 0.58 0.15 1.00 0.52 0.64 0.11
(95% CI) (0.59–2.19) (0.28–1.20) (0.27–0.98) (0.34–1.17)
Atsuage (deep fried tofu)
Tertile median 0.0 2.9 5.9 0.0 3.1 6.4
Cases/controls 29/139 24/137 26/138 20/146 33/146 35/148
OR
a 1.00 0.67 0.70 0.31 1.00 1.95 2.28 0.02
(95% CI) (0.34–1.34) (0.35–1.38) (0.98–3.86) (1.15–4.51)
Aburage (thinly sliced
deep fried tofu)
Tertile median 0.0 0.5 1.4 0.3 0.7 1.9
Cases/controls 23/136 34/136 22/137 22/145 31/147 35/147
OR
a 1.00 1.67 1.07 0.97 1.00 1.75 1.62 0.17
(95% CI) (0.82–3.40) (0.51–2.26) (0.89–3.43) (0.83–3.14)
Natto (fermented
soybeans)
Tertile median 1.2 3.7 8.7 1.3 4.0 10.8
Cases/controls 29/138 26/137 24/137 30/145 30/145 27/148
OR
a 1.00 0.89 0.84 0.56 1.00 1.00 0.79 0.47
(95% CI) (0.46–1.74) (0.43–1.64) (0.54–1.87) (0.41–1.51)
Koyadofu (freeze dried
tofu)
Tertile median 0.0 1.9 3.6 0.0 2.1 4.2
Cases/controls 55/297 6/57 18/60 58/284 14/77 16/79
OR
a 1.00 0.68 1.38 0.52 1.00 0.81 0.99 0.84
(95% CI) (0.27–1.73) (0.69–2.79) (0.40–1.64) (0.50–1.97)
aAdjusted for age, motives for consultation, smoking, drinking, exercise, energy, family history, age at menarche, parity, age at first full-term pregnancy, BMI and age at menopause
for postmenopausal women.
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surge of gonadotropins, and perhaps increase the length of the
menstrual cycle (Cassidy et al, 1994; Lu et al, 1996; Nagata et al,
1997).
There is increasing evidence that dietary factors may play a role
in the production, metabolism, and bioavailability of sex
hormones. Soy-containing diets have long been known to be
typical of some ethnic groups who experience low breast cancer
risk. Soybeans contain a significant amount of the isoflavones
daidzein and genistein, which may exert antioestrogenic effects
and protect epithelial tissue from stimulation by endogenous
oestrogens. There are several possible mechanisms by which soy
isoflavones specifically may modulate the risk of breast carcinoma:
(1) increase of serum levels of sex hormone-binding globulin
(SHBG) (Adlercreutz et al, 1991; Mousavi and Adlercreutz, 1993);
(2) downregulation of enzymes involved in oestrogen biosynthesis,
such as aromatase (Adlercreutz et al, 1993); (3) inhibition of 17b-
hydroxysteroid dehydrogenase type I (Makela et al, 1995); (4)
suppression of the gonadotorpins follicule stimulating hormone
(FSH) and luteinising hormone (LH); (5) change in intestinal flora,
which affect reabsorption of E2 and lower circulating oestrogen
levels (Adlercreutz, 1998). Studies examining the effect of a soy
protein diet on the menstrual cycle have demonstrated a
significant increase in follicular phase length and delay in
menstruation, including suppression of midcycle surges of LH
and FSH, which potentially may reduce the risk of breast cancer
(Cassidy et al, 1994; Lu et al, 1996; Nagata et al, 1998; Kumar et al,
2002). Isoflavones have in fact received a great deal of attention
due to their antiproliferative properties and these would support
the protective effect against breast cancer in premenopausal
women observed in the present study. However, clarification of
effects in postmenopausal women is still required. In this
context it is of interest that isoflavones may exert both oestrogenic
and antioestrogenic properties after modification by intestinal
bacteria.
Soybeans are a unique dietary source of a group of phytochem-
icals and several natural anticarcinogens have now been identified
in soybeans, such as protease inhibitors, phytates, phytosterols,
saponins and lignans. Also, soybeans are an excellent source of
dietary fibre and micronutrients, especially calcium. It will be
important in future epidemiological studies to investigate the
association between intake of soybean products and breast cancer
by obtaining a more complete assessment of soybean intake.
Further studies are required to confirm the ability of the
nutritional profile of soybeans to reduce the risk of breast cancer.
Potential limitations of the present study should be considered.
One methodological issue is selection of base population for
controls. We applied noncancer patients at ACCH as controls
because it is reasonable to assume our cases arise within this
population base. Main reasons to visit at ACCH among cases and
controls were self/family recommendation, referral from other
clinics, and secondary screening after primary screening. Although
distributions of these reasons slightly differ, it was considered in
statistical analyses. Notable point of our control population is its
similarity to general population in terms of exposure of interest,
here dietary pattern. We have compared lifestyle characteristics
between outpatients in ACCH and the 1231 individuals randomly
selected from the general population, and confirmed that they are
not substantially different (Inoue et al, 1997). Possible bias due to
medical background of controls is another potential source of bias;
however, our previous report revealed substantially limited impact
of it. More than 66% of noncancer outpatients at ACCH did not
have any specific medical condition. Remaining 34% of them have
specific diseases, but common part of them were benign tumours
and/or non-neoplastic polyps (13.1%), mastitis (7.5%), digestive
disease (4.1%), or benign gynaecological disease (4.1%) (Hamaji-
ma et al, 1995). This situation is very different from that in the US,
where people visit local general clinics first, and are then referred
to hospitals, which function as secondary and/or specific facilities
for further medical treatment. We therefore conclude that it is
feasible to use noncancer outpatients as controls in epidemiolo-
gical studies with due consideration of age, sex, season, and reason
for visit. The present study was free of recall information bias to
the questionnaire because all data were collected prior to
diagnoses. Eligible controls were not matched, because our
previous study showed that the large number of nonselsected
controls gives a steadier estimate than selected, matched controls
(Hamajima et al, 1994).
Another limitation of the present study included the small
number of cases that are more likely to be due to chance leading to
a false-positive result. Conversely, small sample may lack sufficient
power to detect significant differences. The powers for detection of
the OR of 0.5 for higher vs lower level of total isoflavone intake
were 77% among premenopausal women and 81% among
postmenopausal women, respectively (alpha error¼0.0500, two-
sided). Much larger studies will be required to confirm the impact
of soybean products and isoflavone intake on breast cancer risk
among Japanese women.
A number of risk factors for breast cancer have been established,
most of them related to reproductive events. Evidence from studies
of migrant populations, however, has also implicated environ-
mental or lifestyle factors as being of importance and the diet is
suspected of playing a role. The present study focused on the
Japanese diet, which features a high level of consumption of
soybean products and was able to demonstrate that high
consumption of soybean products reduces the risk in Japanese
premenopausal women. The findings are biologically plausible and
suggested a potential beneficial effect of soybean products and
isofloavones in the prevention of breast cancer.
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